FeNO Testing in Istanbul

What Is a FeNO Test?

FeNO stands for fractional exhaled nitric oxide. The test measures the concentration of nitric oxide in exhaled breath using a suitable device. It provides information about an aspect of airway inflammation and can contribute to an asthma assessment when interpreted with the clinical history and other findings.

At Istanbul Allergy, children and adults can enquire about a consultation and appropriate FeNO testing. Explain whether you are seeking an initial assessment of symptoms, review of an existing asthma diagnosis or interpretation of earlier results. The aim is to understand what the measurement contributes to your care, not simply obtain a number. Our Asthma Treatment page explains the broader management pathway; this page focuses on the breath test, preparation and interpretation.

Airway Inflammation and Type 2 Asthma

Nitric oxide is produced in the body, and its level in exhaled breath can rise in association with certain inflammatory pathways. FeNO is particularly relevant to eosinophilic or Type 2 airway inflammation. It does not measure every form of inflammation or every reason a patient may cough or feel short of breath.

Ask what the clinician is investigating in your case. If asthma is suspected, describe the symptoms and their pattern rather than assuming a high result is needed to validate them. If you already have a diagnosis, ask whether the test is intended to review inflammation, treatment response or another question. Knowing the purpose helps interpret the finding proportionately. FeNO is most useful when it supports a defined clinical decision rather than being presented as a complete explanation of every respiratory symptom.

When Might FeNO Testing Be Useful?

FeNO can contribute to the diagnosis and monitoring of asthma in an appropriate pathway. Clinical guidelines place objective testing alongside the symptom history and examination. The sequence of investigations depends on the patient’s age, findings and treatment circumstances.

Tell the clinician whether symptoms involve wheeze, cough, chest tightness, exercise limitation or episodes of breathlessness. Explain whether the problem is new, intermittent or persistent, and what has already been investigated. Ask what a higher or lower result would change. Testing should help resolve a relevant question rather than be requested solely because a particular device is available. If another assessment is more appropriate, the consultation should clarify that and explain how the next step fits the overall clinical picture.

Prepare a Clear Breathing-Symptom History

Before the appointment, prepare a timeline of symptoms, previous diagnoses, urgent-care visits and treatment. Describe when the problem occurs, what changes it and how it affects daily life. Include symptoms during exercise, sleep, work and different seasons where relevant.

Bring previous lung-function reports, FeNO measurements and the names of inhalers or other medicines. State which treatments are currently used and which were only prescribed but not taken. If a child is being assessed, include caregiver observations and how play or school activities are affected. The history gives meaning to a result measured on one particular day. You do not need to provoke symptoms or withhold treatment to make the assessment useful; explain the normal pattern and ask how the test should be interpreted in that context.

FeNO Testing in Children

The test requires the child to follow a breathing instruction and maintain a controlled, steady exhalation. Whether a reliable result can be obtained depends on the child’s ability to perform the manoeuvre as well as the device and clinical setting. Suitability should be confirmed rather than inferred from age alone.

Tell the team the child’s age and whether breathing tests have been attempted before. Ask how to explain the procedure and what caregiver support is helpful. A calm description of breathing slowly into a mouthpiece may be more useful than calling it an exam the child must pass. If the child cannot complete an acceptable attempt, that does not prove or exclude asthma. The clinician can discuss whether to try again or use another assessment pathway appropriate to the child’s symptoms and circumstances.

Adult Asthma and Respiratory Assessment

Adults may seek FeNO testing for suspected asthma, review of ongoing symptoms or questions about an existing treatment plan. The test should be selected for a clinical purpose and interpreted with the history. It is not a substitute for assessment of other possible causes of respiratory symptoms.

Describe occupational exposures, smoking history, other health conditions and current treatment. Bring reports from earlier respiratory consultations where available. Explain whether your main concern is the diagnosis, symptoms despite treatment or uncertainty about what an earlier number means. Ask what the planned consultation can address and whether another specialist assessment is appropriate. For international patients, clarifying the scope before travel is particularly helpful so that a short visit is not built around an assumption that one breath measurement can settle every question.

How Is FeNO Different From Spirometry?

Spirometry measures aspects of airflow and the amount of air exhaled during a forced breathing manoeuvre. FeNO measures nitric oxide in breath using a different technique. They investigate different aspects of airway disease and can provide complementary information when appropriately selected.

A patient may be asked to complete more than one type of test, but the purpose of each should be explained. Do not assume that a normal result from one method makes another automatically unnecessary. Equally, not every appointment needs every available investigation. Ask which question is being answered and whether additional testing would change the assessment. Preparation can also differ, so confirm instructions for the full appointment rather than applying a spirometry medication or food rule automatically to FeNO alone.

FeNO Is Not a Test for a Particular Allergen

FeNO does not identify whether pollen, house dust mites, an animal or a food is responsible for symptoms. It measures an inflammatory marker rather than allergen-specific sensitisation. If an allergy question is relevant, the clinician may consider a separate assessment based on the history.

Explain any reproducible exposure pattern and previous allergy results. Our Allergy Testing, Skin Prick Test and Allergy Blood Test pages describe those methods. A high FeNO value should not be translated into a new food exclusion diet or a diagnosis of allergy to every positive substance on an unrelated report. Ask the clinician to connect the different findings and explain which ones matter to the respiratory question being investigated.

How to Prepare for Your FeNO Appointment

Some recent activities and exposures can affect the measurement. Patient preparation guidance commonly addresses exercise, smoking, certain drinks and nitrate-rich foods before testing. Obtain the instructions for your actual appointment, including the relevant time intervals, rather than assuming every service uses the same preparation plan.

Leave enough time to arrive without rushing or exerting yourself immediately beforehand. Tell the team if you have already eaten, smoked or exercised contrary to the instructions; report it rather than concealing it. The clinician can decide how that affects the assessment. If several tests are scheduled together, ask for a combined preparation plan that makes clear which instruction applies to which procedure. Preparation should support a useful measurement without creating unnecessary restrictions or interrupting treatment independently.

Should You Stop Inhalers or Other Medicines?

Do not stop inhalers or other prescriptions independently to obtain a FeNO result. Tell the clinician what you take, when it was last used and whether the schedule has changed. Treatment history matters to interpretation, and instructions may differ if spirometry or another procedure is also planned.

Bring inhaler names, active ingredients and devices where practical. If you are unsure whether a product is a controller or reliever, ask the team to clarify. Report recent steroid tablets or injections as well as inhaled treatment. If symptoms worsen before the appointment, follow the prescribed care plan and seek appropriate help rather than withholding medicine to preserve a test. An assessment can be adjusted; immediate breathing needs should not be made dependent on producing an untreated measurement.

How Inhaled Corticosteroids Affect the Result

Inhaled corticosteroid treatment can reduce FeNO, so a measurement obtained during treatment may differ from one before treatment began. This is part of the reason the clinician needs the current prescription and actual use history. A lower value should not be interpreted without knowing the treatment context.

Ask whether the purpose is diagnosis before treatment, assessment during established care or comparison with an earlier result. If another clinician started treatment because symptoms required it, provide that history rather than stopping it to recreate the earlier condition. The review should explain how the result fits what has been used and whether another investigation or follow-up is needed. The goal is safe interpretation of the present situation, not obtaining a particular number by independently changing an effective regimen.

Smoking, Allergy and Other Interpretation Factors

Smoking, atopic or allergic conditions and other clinical factors can influence FeNO. A higher result can occur in circumstances other than asthma, while a lower result does not exclude asthma. The measurement needs to be considered alongside the patient’s symptoms, exposures and treatment.

Give an accurate smoking and exposure history, including relevant changes before the test. Describe nasal allergy symptoms and any recent illness rather than deciding yourself that they are unrelated. Ask which factors may have affected the finding and whether repeating the measurement under an agreed plan would be useful. Do not interpret a reassuring-looking number as evidence that smoking has no respiratory effect or that persistent symptoms no longer need assessment. The result addresses a specific marker, not the full range of possible airway or lung problems.

Recent Illness and a Change in Breathing Symptoms

Tell the team about a recent respiratory infection, new symptoms or a change in asthma control before attending. The clinician should decide whether the planned tests remain appropriate and how the current circumstances affect interpretation. Do not assume every new cough should be managed by simply proceeding with a scheduled measurement.

Explain when the illness began, whether antibiotics or steroids were used and how breathing now compares with usual. If another test is planned, it may have additional suitability requirements. Ask whether the consultation can still be useful even if a particular procedure is postponed. Patients travelling internationally should discuss a significant health change before departure, particularly if the visit is organised around testing. A fixed travel booking should not pressure the patient or clinician to proceed when the clinical situation needs a different approach.

What Happens During the Test?

A trained team member explains how to breathe through the mouthpiece connected to the measuring device. The manoeuvre involves a controlled exhalation rather than the hard, fast blow used in spirometry. Instructions and any feedback from the device help the patient maintain an acceptable attempt.

Ask for a demonstration if the technique is unfamiliar. Keep following the operator’s guidance rather than changing the breath to try to obtain a lower or higher reading. Several attempts may be needed, particularly while learning the technique. Tell the team if you become uncomfortable or need a break. The aim is a technically usable measurement, not a competition or a pass-or-fail test of effort. If an acceptable attempt cannot be obtained, ask how that will be recorded and what alternative assessment may be appropriate.

How Long Does FeNO Testing Take?

The breath measurement itself is brief, but the full appointment includes explanation, preparation review, attempts and interpretation. Additional respiratory tests or a clinical consultation increase the time needed. A short exhalation should not be confused with a guarantee that the entire visit will finish in a few minutes.

Ask the team how much time to allow for the actual booking. If you have a short stay in Istanbul, confirm whether consultation, FeNO and other requested assessments are arranged together. Avoid scheduling an immediate onward journey based only on the device’s measurement time. For children, allow practical time for explanation and a calm attempt. A complete visit should leave you understanding the result and next step, rather than prioritising speed over a useful clinical discussion.

Technique and the Quality of the Measurement

The clinical usefulness of a FeNO result depends on an acceptable measurement as well as appropriate interpretation. The operator should assess whether the patient followed the required technique and whether the device accepted a suitable attempt. A number recorded during a difficult manoeuvre may need further consideration.

Ask whether the result was technically satisfactory and whether more than one attempt was needed. If comparing earlier reports, provide the date, device information where available, treatment and relevant circumstances. Do not try to compare photographs of two device screens without the clinical context. The report should make clear whether a reliable result was obtained or whether technical difficulty limits the assessment. A missing result should not be treated as a normal value or as proof that the patient does not have a respiratory problem.

Understanding ppb and the Reported Value

FeNO is usually expressed in parts per billion, abbreviated to ppb. It describes the concentration of nitric oxide in the measured breath. It is not an oxygen saturation reading, an airflow measurement or a percentage of lung damage.

Ask the clinician to explain the value in relation to the patient’s age, symptoms and current treatment. The same number should not automatically lead to the same conclusion for every patient or testing purpose. A report may use categories, but those categories are part of a clinical interpretation rather than instructions to increase or stop medicines independently. Keep the complete report with the date and relevant history so later comparisons can be made meaningfully instead of relying on a remembered high or low label.

What Can a Higher FeNO Result Suggest?

A higher FeNO can support the presence of eosinophilic airway inflammation and may contribute information about the likelihood of a corticosteroid-responsive process. It must still be interpreted in the clinical context. It does not identify a specific allergen or quantify how damaged the lungs are.

Ask what the finding changes in your assessment. Does it support a diagnosis, prompt review of existing treatment or lead to another investigation? If you already use a controller inhaler, explain actual use and any practical difficulties before a treatment change is considered. A higher result is a reason for clinical interpretation, not an independent instruction to start steroid tablets or obtain an advanced injection. The care plan should explain the next step and how its usefulness will be reviewed.

What Can a Lower FeNO Result Mean?

A low FeNO does not rule out asthma. It may reflect the inflammatory pattern, current treatment or other factors. Persistent respiratory symptoms should not be dismissed solely because this particular marker is not raised.

Ask which possibilities remain and whether lung-function testing, review over time or another assessment would be useful. If a previous asthma diagnosis is being reconsidered, the clinician should explain what evidence supports any change rather than relying on one value alone. Do not stop a prescribed inhaler because a report looks normal. The meaning of the result depends on why it was requested and what treatment was being used. A useful discussion clarifies what the measurement adds while acknowledging the questions it cannot settle.

Borderline or Unexpected Results

Sometimes a result does not fit neatly with the symptom history or earlier tests. That is a reason to review the context rather than automatically assume the patient is wrong or the device has supplied a complete diagnosis. Interpretation should consider preparation, technique, treatment and the clinical question.

Ask what the uncertainty means for care now. Is further testing needed, would an agreed repeat be useful or does another explanation deserve assessment? Provide complete earlier reports rather than only comparing which number is larger. A borderline label should not lead to unsupervised treatment changes or a series of repeated tests without a plan. The clinician should explain what evidence would help resolve the question and what management is appropriate while that assessment continues.

FeNO in Established Asthma Follow-Up

FeNO can be used as an additional tool in selected asthma treatment decisions. ATS guidance addresses its use alongside usual clinical care, rather than as a replacement for symptoms, exacerbation history, lung function and treatment review. Its usefulness depends on how it informs an individual decision.

At follow-up, bring information about daytime and night symptoms, activity, reliever use and urgent-care visits. Explain any treatment changes since the earlier measurement. Ask how the result fits the overall picture and what would count as meaningful improvement. A lower number alone is not the only goal of care; the patient’s comfort, function and future management plan also matter. If treatment is adjusted, clarify the review point and what should prompt earlier contact.

Inhaler Use, Technique and Practical Difficulties

An asthma review should include how prescribed treatment is actually being used. FeNO may contribute to the discussion, but one measurement should not be treated as a complete judgement about adherence or a patient’s effort. The clinician needs the practical history and, where appropriate, a technique review.

Bring the inhaler device and explain any uncertainty, side effects, cost, access problems or difficulty following the schedule. Ask for a demonstration if technique is unclear and discuss what can be simplified. Reporting problems is useful clinical information, not a failure. If you live abroad, confirm how the agreed product or an appropriate locally available equivalent will be managed with your usual clinician. A plan should be feasible after the appointment rather than assume every prescription is immediately accessible and used exactly as written.

Repeat Testing and Comparing Measurements

Repeat testing should answer an agreed question, such as review after a treatment change or reassessment of a previous uncertain finding. Bring the full earlier result and the clinical context. A comparison is more useful when the treatment, symptoms and relevant circumstances are recorded alongside the number.

Ask when a repeat is likely to affect care and what change would lead to a different decision. Do not request frequent measurements simply to keep checking whether the value is normal. If results differ, discuss technique, preparation, medicines and exposure before assuming the disease has permanently worsened or resolved. For international patients, ask whether the repeat needs to be performed in Istanbul or whether a suitable local assessment can be reviewed. A practical follow-up plan should explain how results will be interpreted across visits.

Combining FeNO With Other Assessments

The appropriate asthma assessment may include symptom history, examination and selected objective tests. FeNO and spirometry provide different information, while peak-flow monitoring or other investigations may be relevant in some pathways. The clinician should select the combination according to the patient and purpose.

Ask which tests are planned before arriving and whether their preparation requirements differ. If you have already completed useful investigations, provide them so avoidable repetition can be considered. The team should explain the order of procedures and whether any further review is needed after the results. Do not assume every breathing test is part of one package or that all possible investigations are available in the same setting. Confirm the service scope before travel, especially when the request concerns a complex or changing respiratory problem.

Planning FeNO Testing in Istanbul

Contact Istanbul Allergy with the patient’s age, main symptoms, existing diagnosis and current medicines. Explain whether you want an initial assessment or review of an earlier FeNO or lung-function result. Ask about a consultation with Prof. Dr. Ahmet Akçay and confirm suitable testing before booking travel.

Our address is Harbiye Mah., Teşvikiye Cad., Karaosmanoğlu Apartmanı, No: 37, Floor 3, Şişli, Istanbul, opposite City’s Shopping Mall. Confirm consultation language, arrival details and how records should be provided. Ask whether translation is needed. The Plan Your Visit page offers practical preparation information. If breathing has recently worsened, tell the team in advance rather than assuming the appointment should proceed unchanged because flights or accommodation have already been arranged.

Costs, Results and Online Follow-Up

Ask what the consultation and FeNO fees include and whether any additional lung-function or allergy investigation is priced separately. Confirm who will interpret the result and whether a later review is included. This page does not promise one package covering every respiratory test or a fixed completion time for every assessment.

Selected history discussions, existing-report reviews or follow-up questions may be suitable for an online consultation. The device measurement itself needs appropriate in-person arrangements. If you live abroad, ask how findings will be shared with your usual clinician and how ongoing care should be organised. Before the visit ends, make sure you understand the result, what remains uncertain, the treatment advice and the next review point. Receiving a number should be the beginning of an explanation, not the end of the assessment.

When Breathing Symptoms Need Urgent Care

A planned FeNO appointment is not a way to manage an ongoing asthma attack or serious breathing difficulty. Follow your prescribed asthma action plan and seek urgent local care when symptoms are severe or worsening. In Turkey, call 112 for an emergency.

Do not delay necessary treatment to obtain an untreated test result. Asthma pathways advise immediate treatment for patients who are acutely unwell or highly symptomatic rather than waiting for objective testing to be completed. Routine WhatsApp and appointment channels are for planned care. After urgent assessment, keep the treatment records and arrange the recommended follow-up. A later consultation can consider which investigations remain useful and how to interpret measurements in light of the treatment already given.

YOUR QUESTIONS

FeNO Testing: Frequently Asked Questions

Scientific Sources & Further Reading

General information cannot establish an individual asthma diagnosis or justify independent treatment changes. Suitability, preparation, interpretation and follow-up are confirmed through clinical assessment.

1. American Thoracic Society: Interpretation of exhaled nitric oxide for clinical applications. ↗
2. American Thoracic Society: FeNO-guided asthma treatment guideline, 2021. ↗
3. BTS/NICE/SIGN: Asthma diagnosis, monitoring and management, NG245. ↗
4. NHS England: FeNO patient information and preparation. ↗
5. North Tees and Hartlepool NHS: Children’s breathing tests. ↗
6. Evelina London: Children’s allergy assessments, including FeNO. ↗
7. Royal Wolverhampton NHS: Fractional exhaled nitric oxide testing. ↗
8. NHS: Spirometry. ↗
9. NHS: Asthma and urgent symptoms. ↗
10. American Lung Association: Exhaled nitric oxide testing. ↗
11. GINA: Global Strategy for Asthma Management and Prevention, 2026. ↗
12. NHS Scotland: Initial clinical assessment in the BTS/NICE/SIGN asthma pathway. ↗